Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Poseida Therapeutics
Poseida Therapeutics
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
Pharma Live
Wed, 01/8/25 - 11:25 am
Roche
M&A
Poseida Therapeutics
blood cancer
Roche said it didn’t want to buy Poseida last year: A look at how the $1.5B buyout came to be
Fierce Biotech
Tue, 12/10/24 - 10:00 pm
Roche
Poseida Therapeutics
M&A
cell therapy
Roche to buy cell therapy developer Poseida for $1B
BioPharma Dive
Tue, 11/26/24 - 11:24 am
Roche
Poseida Therapeutics
M&A
cell therapy
cancer
Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal
BioPharma Dive
Wed, 05/1/24 - 10:56 am
Astellas Pharma
Poseida Therapeutics
solid tumors
cell therapy
It’s official: Roche is a Car-T player
EP Vantage
Wed, 08/3/22 - 10:42 am
Roche
CAR-T
oncology
Poseida Therapeutics
Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on the shelf
Fierce Biotech
Wed, 11/10/21 - 10:22 am
Poseida Therapeutics
CAR-T
BCMA
Takeda
Poseida, Takeda partner to develop eight in vivo gene therapy programs
Pharmaceutical Business Review
Wed, 10/13/21 - 10:51 am
Takeda
Poseida Therapeutics
gene therapy
drug development
A year after a death and accompanying trial hold, Poseida hopes for reprieve with early solid tumor CAR-T data
Fierce Biotech
Tue, 08/31/21 - 11:05 am
Poseida Therapeutics
clinical trials
patient deaths
solid tumors
CAR-T
A couple months after landing $100 million in funding, Cellares grabs partner for its Cell Shuttle
Endpoints
Wed, 07/14/21 - 10:15 am
Cellares
Cell Shuttle
cell therapy
Poseida Therapeutics
Poseida shares plunge after death in solid tumor CAR-T trial, clinical hold
Fierce Biotech
Tue, 08/18/20 - 11:05 pm
Poseida Therapeutics
solid tumors
CAR-T
SEC
prostate cancer
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments
Xconomy
Mon, 07/13/20 - 11:33 pm
biotech
IPOs
Nkarta Therapeutics
Poseida Therapeutics
Inventiva
Another four biotechs scratch out the first number and ask for more as IPO boom continues
Endpoints
Fri, 07/10/20 - 11:00 am
IPOs
biotech
Relay Therapeutics
Nkarta Therapeutics
Poseida Therapeutics
Inventiva
Poseida Therapeutics guns again for IPO
Fierce Biotech
Mon, 06/22/20 - 10:32 am
Poseida Therapeutics
CAR-T
IPOs
CAR-T Drugmaker Poseida Snags $142 Million in Financing Led by Novartis
BioSpace
Mon, 04/22/19 - 10:12 am
Poseida Therapeutics
Novartis
CAR-T
Poseida pitches a $115M IPO on its claim that the science team has created a better BCMA CAR-T
Endpoints
Sun, 01/6/19 - 01:58 pm
Poseida Therapeutics
IPOs
BCMA
CAR-T
Poseida Therapeutics Prepares for IPO to Advance CAR-T Treatments
Xconomy
Sat, 01/5/19 - 12:11 am
Poseida Therapeutics
CAR-T
IPOs
solid tumors